Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways

Clinical success of chimeric antigen receptor (CAR) T cell immunotherapy requires the engineering of autologous T cells, which limits the broader implementation of CAR cell therapy. The development of allogeneic and universal cell products will significantly broaden their application and reduce cost...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yan Yang, Saiaditya Badeti, Hsiang-chi Tseng, Minh Tuyet Ma, Ting Liu, Jie-Gen Jiang, Chen Liu, Dongfang Liu
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2020-09-01
Col·lecció:	Molecular Therapy: Methods & Clinical Development
Matèries:	NK CAR expansion CAR-NK cytotoxicity CD19-CAR-NK
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2329050120301388
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!